Rebecca J Ingram Selected Research

Sepsis (Septicemia)

11/2022	Secretory Leucoprotease Inhibitor (SLPI) Promotes Survival during Acute Pseudomonas aeruginosa Infection by Suppression of Inflammation Rather Than Microbial Killing.
6/2009	A role of cellular prion protein in programming T-cell cytokine responses in disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca J Ingram Research Topics

Disease

17	Infections 08/2023 - 06/2009
9	Anthrax 09/2022 - 04/2010
5	Cutaneous anthrax 09/2022 - 04/2010
4	Inflammation (Inflammations) 11/2022 - 01/2018
3	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 09/2017
3	Bacterial Infections (Bacterial Infection) 01/2019 - 04/2010
2	Sepsis (Septicemia) 11/2022 - 06/2009
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2022 - 02/2016
2	Lung Injury 02/2016 - 06/2014
2	Pseudomonas Infections 02/2016 - 01/2012
1	Necrosis 03/2024
1	Persistent Infection 08/2023
1	Pneumonia (Pneumonitis) 11/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Dysbiosis 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Acute Lung Injury 06/2014
1	Central Nervous System Diseases (CNS Diseases) 10/2013
1	Wounds and Injuries (Trauma) 07/2012
1	Bacteremia 06/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2009
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2006

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 04/2010
6	EpitopesIBA 09/2022 - 11/2006
6	VaccinesIBA 09/2022 - 11/2006
5	AntigensIBA 09/2022 - 07/2012
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2006
4	CytokinesIBA 11/2022 - 06/2009
4	anthrax toxin (anthrax lethal factor)IBA 09/2022 - 09/2010
3	Anthrax Vaccines (Vaccines, Anthrax)IBA 09/2022 - 04/2010
3	Interleukin-17 (Interleukin 17)IBA 02/2016 - 06/2009
2	InflammasomesIBA 01/2022 - 01/2018
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2019 - 01/2012
2	Peptides (Polypeptides)IBA 01/2015 - 05/2014
2	Subunit VaccinesIBA 05/2014 - 09/2010
2	Immunodominant EpitopesIBA 05/2014 - 11/2006
1	Dinoprostone (PGE2)FDA Link 03/2024
1	lipoteichoic acidIBA 11/2022
1	ChemokinesIBA 11/2022
1	edema factorIBA 09/2022
1	ExotoxinsIBA 09/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	cathepsin SIBA 01/2021
1	Cysteine Proteases (Cysteine Protease)IBA 01/2021
1	Capsules (Microcapsules)IBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	CuprizoneIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	LactoferrinIBA 12/2018
1	hypothiocyanite ion (OSCN-)IBA 12/2018
1	Interferon Type IIBA 11/2017
1	Tobramycin (Nebcin)FDA LinkGeneric 09/2017
1	ivacaftorIBA 09/2017
1	Antimicrobial PeptidesIBA 09/2017
1	VitaminsIBA 01/2017
1	LipocalinsIBA 01/2017
1	Hepatitis B e AntigensIBA 01/2015
1	Interleukin-5 (Interleukin 5)IBA 01/2015
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 06/2014
1	Fibroblast Growth Factor 7 FDA Link 06/2014
1	AntibodiesIBA 05/2014
1	Heroin (Diamorphine)IBA 02/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2013
1	salicylhydroxamic acid (SHAM)IBA 07/2012
1	AminoglycosidesIBA 01/2012
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2010
1	Indicators and Reagents (Reagents)IBA 11/2006

Therapy/Procedure

1	Intraperitoneal Injections 11/2022
1	Therapeutics 09/2017